sikalische Medizin Akademischer Bericht 2004 - Rheumaklinik ...

14. Schedel J, Seemayer CA, Pap T, Neidhart M, Kuchen S, Michel BA, Gay RE, Müller-Ladner U, Gay S and Zacharias W: Targe-
ting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis.
Gene Therapy:1-8, 2004.
15. Schedel J, Distler O, Woenckhaus M, Gay RE, Simmen B, Michel BA, Müller-Ladner U, Gay S: Discrepancy between mRNA
and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid
arthritis. Ann Rheum Dis 63:1205-1211, 2004.
16. Studynkova JT, Kuchen S, Jeisy E, Schedel J, Charvat F, Jarosova K, Sprott H, Matucci Cerinic M, Gay RE, Michel BA, Pavelka
K, Vencovsky J, Gay S: The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle
tissue of patients with polymyositis and dermatomyositis. Clin Exp Rheumatol 22:395-402, 2004.
17. Joos B, Uebelhart D, Michel BA, Sprott H: Influence of an outpatient multidisciplinary pain management program on the health-
related quality of life and the physical fitness of chronic pain patients. J Neg Res BioMed 3:1-10, 2004.
18. Mannion A, Knecht K, Balaban G, Dvorak J, Grob D: A new skin-surface device for measuring the curvature and global and
segmental ranges of motion of the spine: reliability of measurements and comparison with data reviewed from the literature.
Spine 13:122-136, 2004.
19. Uebelhart D, Malaise M, Marcolongo R, De Vathaire F, Piperno M, Mailleux E, Fioravanti A, Matoso L, Vignon E: Intermittent
treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus
placebo. Osteoarthritis Cartilage 12:269-276, 2004.
20. Dreinhöfer K, Stucki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A: ICF core sets for osteoarthri-
tis. J Rehabil Med 44:1-7, 2004.
21. Staerkle R, Mannion A, Elfering A, Junge A, Semmer N, Jacobshagen N, Grob D, Dvorak J, Boos N: Longitudinal validation of
the Fear-Avoidance Beliefs Questionnaire (FABQ) in a Swiss-German sample of low back pain patients. Eur Spine J 13(4):332-
340, 2004.
22. Stucki A, Daansen P, Fuessli M, Cieza A, Huber E, Atkinson R, Kostanjsek N, Stucki G, Ruof J: ICF core sets for obesity. J Re-
habil Med 44:107-117, 2004.
23. Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, Bliddal H, Uebelhart D, Adami S, Navarro F, Lee
A, Moore A, Gimona A: Lumiracoxib is effective in the treatment of osteoarthritis of the knee: A 13-week, randomized, double-
blind study versus placebo and celecoxib. Ann Rheum Dis 63:1419-1426, 2004.
24. Uebelhart D, Uebelhart B: Ein einfacher Test, um das Osteoporose-Risiko bei der postmenopausalen Frau zu beurteilen. Psy-
che und Soma 9:198-199, 2004.
25. Zennaro D, Läubli T, Krebs D, Krueger H, Klipstein A: Trapezius muscle motor unit activity in symptomatic participants during
finger tapping using properly and improperly adjusted desks. Human Factors 46:252-266, 2004.
26. Wildi LM, Kurrer MO, Benini A, Weishaupt D, Michel BA, Brühlmann P: Pseudocystic degeneration of the lumbar ligamentum
flavum: A little known entity. J Spin Dis Tech 17(5):395-400, 2004.
27. Angst F, Pap G, Mannion AF, Herren DB, Aeschlimann A, Schwyzer HK, Simmen BR. Comprehensive assessment of clinical
outcome and quality of life after total shoulder arthroplasty: usefulness and validity of subjective outcome measures. Arthritis
Rheum 51:819-828, 2004.
28. Joos B, Uebelhart D, Michel BA, Sprott H. Influence of an outpatient multidisciplinary pain management program on the health-
related quality of life and the physical fitness of chronic pain patients. JNRBM 3, 2004.
26